The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 15th 2025
The approved injection contains dihydroergotamine (DHE), which is the same medication used in hospitals, in a ready-to-use device.
What Are the Pharmacist-Preferred Treatments for Coughs and Colds?
July 8th 2018Thousands of pharmacists were polled for their over-the-counter recommendations in a variety of categories. The picks showed that although they aren’t all in agreement, pharmacists do have some clear favorites when it comes to OTC products for treating coughs, colds, and seasonal allergies.
Read More
Mobile App Boosts Adherence, Viral Suppression For Patients With HIV
June 28th 2018Researchers at the University of Virginia developed an app called PositiveLinks to test out whether interactive smartphone functions and reminders could have a real-world impact on the health of HIV-positive patients.
Read More
FDA Advisory Committee Recommends Against Approving Abuse-Deterrent Pain Med
June 28th 2018The FDA voted against recommendign oxycodone extended-release capsules (REMOXY ER, Pain Therapeutics) for approval for the management of pain severe enough to require long-term, around-the-clock opioid treatment, during a joint meeting of the agency’s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), and the Drug Safety and Risk Management Advisory Committee (DSARM).
Read More
Combo Treatment for Advanced BRAF-Mutant Melanoma Receives FDA Approval
June 27th 2018The FDA has granted approval to Array BioPharma’s encorafenib (Braftovi) capsules in combination with binimetinib (Mektovi) tablets for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E or BRAFV600K mutation.
Read More